BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23777742)

  • 1. How can innovative forms of clinical research contribute to deliver affordable cancer care in an evolving health care environment?
    Burock S; Meunier F; Lacombe D
    Eur J Cancer; 2013 Sep; 49(13):2777-83. PubMed ID: 23777742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare reform: innovations at the state level. Coopers & Lybrand Health Decisions Resource Group.
    Nurs Manage; 1994 Apr; 25(4):30-5, 38-40, 42. PubMed ID: 8159342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global health needs to fill the innovation gap.
    Mundel T
    Nat Med; 2012 Dec; 18(12):1735. PubMed ID: 23223055
    [No Abstract]   [Full Text] [Related]  

  • 5. From Bench to Bedside: Targeted Therapy, Denosumab, and 21st Century Orthopaedics: Targets Abound, But Where Are The Therapies?
    Potter BK
    Clin Orthop Relat Res; 2016 Apr; 474(4):892-4. PubMed ID: 26872915
    [No Abstract]   [Full Text] [Related]  

  • 6. Deal watch: Roles and strategies for health foundations in public-private partnerships.
    de Vrueh RL; Awad W; Stolk A; Dijcks FA; Rijnders TW; Janssen JW
    Nat Rev Drug Discov; 2014 Jun; 13(6):406. PubMed ID: 24875086
    [No Abstract]   [Full Text] [Related]  

  • 7. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repairing the broken market for antibiotic innovation.
    Outterson K; Powers JH; Daniel GW; McClellan MB
    Health Aff (Millwood); 2015 Feb; 34(2):277-85. PubMed ID: 25646108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The cost of chemotherapy].
    Lévy C; Bonastre J
    Bull Cancer; 2003 Nov; 90(11):976-82. PubMed ID: 14706901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2012 ISMRM Lauterbur Lecture. MRI: from science to society.
    Lee VS
    J Magn Reson Imaging; 2013 Apr; 37(4):753-60. PubMed ID: 23441004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fostering innovation in medicine and health care: what must academic health centers do?
    Dzau VJ; Yoediono Z; Ellaissi WF; Cho AH
    Acad Med; 2013 Oct; 88(10):1424-9. PubMed ID: 23969357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis & commentary. How health care reform must bend the cost curve.
    Cutler D
    Health Aff (Millwood); 2010 Jun; 29(6):1131-5. PubMed ID: 20530342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the critical list: the US institution of medicine.
    Supri S; Malone K
    Am J Med; 2011 Mar; 124(3):192-3. PubMed ID: 21396498
    [No Abstract]   [Full Text] [Related]  

  • 14. [Private health insurance in Brazil: approaches to public/private patterns in healthcare].
    Sestelo JA; Souza LE; Bahia L
    Cad Saude Publica; 2013 May; 29(5):851-66. PubMed ID: 23702992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accountable care organizations: the case for flexible partnerships between health plans and providers.
    Goldsmith J
    Health Aff (Millwood); 2011 Jan; 30(1):32-40. PubMed ID: 21209435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends and issues in oncology costs.
    Scalo JF; Rascati KL
    Expert Rev Pharmacoecon Outcomes Res; 2014 Feb; 14(1):35-44. PubMed ID: 24328809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Era of personalized medicine may herald end of soaring cancer costs.
    Keogh B
    J Natl Cancer Inst; 2012 Jan; 104(1):12-3, 16-7. PubMed ID: 22173586
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimising translational oncology in clinical practice: strategies to accelerate progress in drug development.
    Stahel R; Bogaerts J; Ciardiello F; de Ruysscher D; Dubsky P; Ducreux M; Finn S; Laurent-Puig P; Peters S; Piccart M; Smit E; Sotiriou C; Tejpar S; Van Cutsem E; Tabernero J
    Cancer Treat Rev; 2015 Feb; 41(2):129-35. PubMed ID: 25533737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient Protection and Affordable Care Act of 2010: reforming the health care reform for the new decade.
    Manchikanti L; Caraway DL; Parr AT; Fellows B; Hirsch JA
    Pain Physician; 2011; 14(1):E35-67. PubMed ID: 21267047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.